PRWeb
prCenter
BS PHARM KOREA Strengthens INHILO+ Market Development Through Distribution and Clinical Collaborationtranslating…
The Dual-Molecular HA skin booster advances its market development through clinical data, domestic distribution with Dongkook Pharmaceutical, and an ongoing clinical evaluation program in South Korea. SEOUL, South Korea, Sept. 6, 2026 /PRNewswire-PRWeb/ -- BS PHARM KOREA is…
Keywords#KOREA#Clinical#PHARM KOREA#BS PHARM#Development Through
Comments
Sign in to join the discussion.
Loading comments…